Announcement  by unknown
296 DAVIES ET AL 
CoHN: I was interested to see that you are finding arachidonic 
acid release under these conditions. We also found this recently. 
I wonder whether you h ave looked at the activity of phospho-
lipases and whether this might be the controlling factor in 
release of arachidonic acid . 
DAVIES: Yes, this is something that we are studying at the 
moment. We can say t hat macrophages conta in at least 2 
phospholipases. These have been shown to hydrolyze purified 
radiolabeled phospholipids obtained from LM cells grown in 
culture and by ident ification of the products of hydrolysis we 
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can show them to be phospholipases A2. There may well be 
other phospolipases present in macrophages. The characteri-
zation of these enzymes will be important in terms of the 
regulation of arachidonic acid metabolism by macrophages. 
LICHTENSTEIN: Along the same line, does the addition of 
arachidonic acid cause the cells without an additional stimulus 
to make prostaglandins. 
DAVIES: We have no evidence that macrophages can directly 
utilize exogenous free arachidonic acid and convert it into any 
of the oxygenation products. 
Announcement 
Stanford University's Department of Dermatology is present ing the Third International Psoriasis 
Symposium, to be held July 13-17, 1981, at Stanford University. Significant advances in psoriasis research 
and therapy will be emphasized through plenary sessions, workshops and poster exhibits, during which 
opportunities for direct discussions between investigators and attendees will be provided. For further 
information please contact: Paul H . Jacobs, M.D., Dermatology Department, Stanford University School 
of Medicine, Stanford, CA 94305. 
